Royalty Pharma to Present at Upcoming Investor Conferences
September 06 2022 - 4:15PM
Royalty Pharma plc (Nasdaq: RPRX) today announced that it will
participate in the following upcoming investor conferences during
the month of September:
- Citi’s 17th Annual BioPharma Conference on Thursday, September
8 at 11:20 a.m. ET
- Morgan Stanley’s 20th Annual Global Healthcare Conference on
Monday, September 12 at 10:30 a.m. ET
- Bank of America’s Global Healthcare Conference 2022 on
Thursday, September 15 at 10:55 a.m. ET / 3:55 p.m. BST
The webcasts will be accessible from Royalty Pharma’s “Events”
page at
https://www.royaltypharma.com/investors/news-and-events/events.
Webcasts will also be archived for a minimum of thirty days.
About Royalty Pharma plc
Founded in 1996, Royalty Pharma is the largest buyer of
biopharmaceutical royalties and a leading funder of innovation
across the biopharmaceutical industry, collaborating with
innovators from academic institutions, research hospitals and
non-profits through small and mid-cap biotechnology companies to
leading global pharmaceutical companies. Royalty Pharma has
assembled a portfolio of royalties which entitles it to payments
based directly on the top-line sales of many of the industry’s
leading therapies. Royalty Pharma funds innovation in the
biopharmaceutical industry both directly and indirectly - directly
when it partners with companies to co-fund late-stage clinical
trials and new product launches in exchange for future royalties,
and indirectly when it acquires existing royalties from the
original innovators. Royalty Pharma’s current portfolio includes
royalties on more than 35 commercial products, including Vertex’s
Trikafta, Kalydeco, Orkambi and Symdeko, Biogen’s Tysabri, AbbVie
and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s
Xtandi, GSK’s Trelegy, Novartis’ Promacta, Biohaven and Pfizer’s
Nurtec ODT, Johnson & Johnson’s Tremfya, Roche’s Evrysdi,
Gilead’s Trodelvy, and 11 development-stage product candidates.
Royalty Pharma Investor Relations and
Communications
+1 (212) 883-6772ir@royaltypharma.com
Royalty Pharma (NASDAQ:RPRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Royalty Pharma (NASDAQ:RPRX)
Historical Stock Chart
From Jul 2023 to Jul 2024